Skip to main content
. 2014 Jul 23;2014:235060. doi: 10.1155/2014/235060

Table 2.

Effect of IGF-1 administration on osteoporosis and bone metabolism.

Authors n. subjects Age Dosage
μ/kg/day
Duration BF BR Clinical effects
Johansson et al., 1992 [262] 1 M 80 μ/kg/day × 2 Bone formation markers increased

Ebeling et al., 1993 [263] 18 PMO 74 ± 0.2 
66.3 ± 7.8 
67.4 ± 5.5 
58.6 ± 4.4
30 
60 
120 
180
7 days Significant dose-dependent BR, less BF. Longer treatments are suggested

Rubin et al., 1994 [264] 1 W, Werner syndrome, low serum IGF-1 level, and osteoporosis. 30–75 6 months Lumbar bone mass increased 3% BMD

Grinspoon et al., 1995 [265] 14 W normal 19–33 100 μ  ×  2 6 days Increase bone formation

Ghiron et al., 1995 [266] 16 w 
healthy
71.9 ± 1.3 60, 15 μ (diet also) 28 days Increase bone mass

Johansson et al., 1996 [257] 12 M IO 44 ± 8 80 µ 7 days Enhanced bone formation and bone resorption

Grinspoon et al., 1996 [267] 23 W 18–29 200, 60 µ 6 days Increases markers of bone turnover

Mauras et al., 1996 [268] 5 M + 3 W 
3 M + 2 W
23–27 
23–25
240 µ
100 µ
5–7 days Synergize with sex steroids to maximally stimulate attainment of peak bone mass in humans

Bianda et al., 1997 [245] 7 M 192 µ 5 days Serum osteocalcin and PICP, the urinary deoxypyridinoline/creatinine, and calcium/creatinine ratios got significantly higher

Berneis et al., 1999 [159] 24 M 
healthy
24.5 ± 1.2 GH = 0.15 × 2 IU/kg/day 
+ 
IGF-1 = 80 µ
6 days Markedly counteracts diminished bone and body collagen synthesis caused by glucocorticoids

Friedlander et al., 2001 [269] 24 PMO 72 ± 2.7 15 µ/kg twice daily 1 year No effect

Boonen et al., 2002 [270] 30 W 65–90 0.5–1 µ/kg/d 8 weeks Effects on bone mass, muscle strength, and functional ability, beneficial trends

Grinspoon et al., 2002 [271] 60 W 
osteopenia 
with anorexia
18–38 30 μg/kg sc 
twice daily
9 months Increased mIGFBP-2 and decreased IGFBP-3 and bone density increased

Grinspoon et al., 2003 [272] 65 W 
anorexia 
nervosa
25.6 ± 0.8 30 μg/kg sc 
twice daily
9 months IGF-I and IGFBP-3 are independent predictors of bone density

Misra et al., 2009 [273] 10 W
low bone 
density and anorexia
12–18 30–40 mcg/k 
twice daily
7–9 days Increase in PINP, a bone formation marker

M = men, W = women, PMO = postmenopausal women, MIO = men with idiopatic osteoporosis, BR = bone resorption, BF = bone formation.